POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,667,287 | -84.3% | 249,968 | -78.6% | 0.01% | -83.6% |
| Q2 2023 | $10,592,073 | +24.6% | 1,169,103 | 0.0% | 0.06% | +32.6% |
| Q1 2023 | $8,499,379 | -0.3% | 1,169,103 | 0.0% | 0.05% | -9.8% |
| Q4 2022 | $8,522,761 | -5.7% | 1,169,103 | 0.0% | 0.05% | -13.6% |
| Q3 2022 | $9,037,000 | – | 1,169,103 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,909,960 | $19,409,433 | 3.54% |
| JOHNSON & JOHNSON | 1,000,000 | $6,670,000 | 2.46% |
| BVF INC/IL | 10,563,748 | $70,460,199 | 1.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,354,122 | 1.16% |
| Boxer Capital, LLC | 2,500,000 | $16,675,000 | 0.89% |
| Pier Capital, LLC | 732,936 | $4,888,683 | 0.79% |
| Deep Track Capital, LP | 2,781,565 | $18,553,039 | 0.72% |
| PFM Health Sciences, LP | 1,613,516 | $10,762,152 | 0.51% |
| Eagle Health Investments LP | 306,142 | $2,041,967 | 0.45% |
| Onex Canada Asset Management Inc. | 772,905 | $5,155,276 | 0.40% |